Ads
related to: phase 3 fda clinical trials
Search results
FDA Advisers Overwhelmingly Oppose Approval of MDMA As a Psychotherapeutic Catalyst
Reason.com via Yahoo News· 7 hours agoThe researchers described the placebo as "inactive," meaning it did not even have the stimulating...
Adial begins pharmacokinetic study for AUD treatment By Investing.com
Investing.com· 10 hours agoAdial Pharmaceuticals, Inc. (NASDAQ:ADIL), a clinical-stage biopharmaceutical company, announced the...
FDA Panel Rejects Use of MDMA-Assisted Therapy for PTSD
Healthline via AOL· 18 hours agoAn expert panel of the Food and Drug Administration reviewed finding from two phase 3 clinical...
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
Zacks via Yahoo Finance· 1 day agoDenali's (DNLI) DNL126, an investigational enzyme replacement therapy, gets selected for the START...
EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol...
Benzinga via Yahoo Finance· 16 hours ago:ADIL) announced that the first patient had been dosed in a pharmacokinetics study of AD04 for...
SciTech Development secures additional funding for cancer trials
Clinical Trials Arena via Yahoo Finance· 17 hours agoIn...raise to fund the completion of both trials and file for commercial approval with the FDA.”...
Lykos' MDMA treatment rejected by FDA committee, despite being '75% of the way there'
FierceBiotech· 13 hours agoLykos Therapeutics’ attempt to get the first ever MDMA treatment approved in post-traumatic stress...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
NBC News via Yahoo News· 1 day agoA Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA,...
Denali, Neurogene and more picked by FDA's 'Operation Warp Speed' for rare disease
FierceBiotech· 1 day agoThe FDA’s “Operation Warp Speed” equivalent for rare disease will include programs from Denali...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 7 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
